Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Biotest announces strong profit growth for 2012

Biotest announces strong profit growth for 2012

2nd April 2013

Biotest was able to achieve significant profit growth during the 2012 business year, according to the healthcare company's final results for the 12-month period.

The group's sales from continuing operations last year came to 422 million euros (356.64 million pounds), up by 4.3 percent on 2011, while profits after tax surged by 23.5 percent year-on-year to 23.1 million euros.

Earnings before interest and taxes (EBIT) also increased significantly during the period, thanks to strong performance from Biotest's business operations outside of Europe and its ongoing efforts to improve efficiency and reduce costs.

The company said: "We expect the group's sales in the financial year 2013 to grow 10 percent to 15 percent annually. With regard to EBIT, we expect a comparable performance in 2013."

Earlier this year, Biotest announced a new strategic long-term manufacturing, supply and license agreement with ADMA Biologics concerning RI-002, a promising respiratory syncytial virus immune globulin therapy.ADNFCR-8000103-ID-801564983-ADNFCR

We currently have 10 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.